ACE2 and inflammatory bowel disease: It is believed that the entry of SARS-CoV-2 into human tissues is facilitated via angiotensin-converting enzyme 2 (ACE-2), which is highly expressed in the intestine, especially in colonocytes of healthy subjects and in patients with inflammatory bowel disease [4,5].